Lyra Therapeutics announces new chief legal officer

Clinical-stage biotechnology company Lyra Therapeutics announced the appointment of Ronan O’Brien as chief legal officer.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.